Advances in research on molecular biological markers for the differential diagnosis of thyroid neoplasms
- VernacularTitle:甲状腺肿瘤术前鉴别诊断的分子标志物研究进展
- Author:
Tuanqi SUN
;
Yi WU
;
Zhuoying WANG
- Publication Type:Journal Article
- Keywords:
thyroid neoplasms;
differential diagnosis;
biological marker
- From:
China Oncology
2001;0(02):-
- CountryChina
- Language:Chinese
-
Abstract:
Thyroid neoplasm is one of the most common endocrinal tumors. In general, thyroid cancer patients are usually presented with asymptomatic neck nodules. A differential diagnosis between malignant and benign thyroid neoplasm is very important for these patients. This review article primarily discusses biological markers used to aid the differential diagnosis of thyroid neoplasia, which may lead to a more rational approach to the treatment. It mainly describes the recent development of molecular biological markers VEGF-C, Cytokeratin-19, HBME-1, Pax8-PPAR and Galectin-3 for the differential diagnosis of thyroid neoplasms.
